The Prevent Cancer Foundation® is joining the National Alliance of State and Territorial AIDS Directors’ (NASTAD) Hepatitis Testing Partnership for a webinar tomorrow, October 23 at 3:00 p.m. ET!
The webinar, titled Hepatitis Prevention, Testing, and Treatment as Liver Cancer Prevention, will explore the connection between liver cancer and viral hepatitis, and examine how hepatitis vaccination, testing and treatment can prevent liver cancer.
Liver cancer is the fastest-rising cause of cancer death in the U.S., taking the lives of almost 29,000 Americans this year alone. Up to 50 percent of liver cancer cases are related to hepatitis B and up to 60 percent are related to hepatitis C. There is a vaccine to protect against hepatitis B, and testing and treatment available for hepatitis C. October is Liver Cancer Awareness Month, so now is the perfect time to talk about hepatitis and liver cancer.
During the webinar, we’ll be sharing insights from our Think About the Link® campaign that highlight the relationship between hepatitis B and C and liver cancer. Two of our community grantees, Hepatitis B United-Philadelphia and the Iowa Harm Reduction Coalition, will discuss their work integrating liver cancer prevention into hepatitis education, prevention, testing and treatment efforts.
We hope you’ll join us for this important conversation!
Register for the webinar here.